Abstract
Mono-, di-, and trinucleoside conjugates of glutamate or peptide scaffolds containing nucleoside reverse transcriptase inhibitors were synthesized. Among dinucleoside glutamate ester derivatives, N-myristoylated derivatives showed significantly higher anti-HIV activity than the corresponding N-acetylated conjugates against cell-free virus. Myristoyl-Glu(3TC)-FLT (46, EC(50) = 0.3-0.6 μM) and myristoyl-Glu(FTC)-FLT (47, EC(50) = 0.1-0.4 μM) derivatives were the most active glutamate-dinucleoside conjugates. A trinucleoside glutamate derivative containing AZT, FLT, and 3TC (34, EC(50) = 0.9-1.4 μM) exhibited higher anti-HIV activity than AZT and 3TC against cell-free virus. Compound 34 also exhibited higher anti-HIV activity against multidrug (IC(50) = 5.9 nM) and NNRTI (IC(50) = 12.9 nM) resistant viruses than parent nucleosides. The physical mixture containing FLT-succinate, AZT, 3TC, and glutamic acid exhibited 115-fold less activity against cell associated virus (EC(50) = 91.9 μM) when compared to 34 (EC(50) = 0.8 μM). Other conjugates showed less or comparable potency to that of the corresponding physical mixtures.
References
Mar 11, 1991·AIDS Research and Human Retroviruses·R W Buckheit, R Swanstrom
Apr 29, 1988·Science·H MitsuyaS Broder
Aug 26, 1998·Nucleosides & Nucleotides·K ParangL I Wiebe
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·S G SarafianosE Arnold
Apr 20, 2001·Journal of Virology·K DasE Arnold
Mar 29, 2003·Drugs·Risto S Cvetkovic, Karen L Goa
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Karidia DialloM A Wainberg
Dec 12, 2003·Nature Reviews. Drug Discovery·K Ravi AcharyaMario R W Ehlers
Jul 22, 2004·Bioconjugate Chemistry·Ying ChauRobert Langer
Mar 30, 2005·Expert Opinion on Pharmacotherapy·Adriano Lazzarin
Sep 13, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fred C KrebsBrian Wigdahl
Sep 28, 2005·International Journal of Cancer. Journal International Du Cancer·Ying ChauRobert Langer
Jan 19, 2006·Journal of Pharmaceutical Sciences·Ying ChauRobert Langer
Apr 6, 2007·Antiviral Research·Katherine E GantlettQuentin J Sattentau
Sep 14, 2007·Journal of Pharmaceutical Sciences·Suman PenugondaReza Mehvar
Apr 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Lubbertus C F MulderViviana Simon
May 6, 2008·International Journal of Pharmaceutics·Sheetal AgarwalAshim K Mitra
Jun 21, 2008·Molecular Cancer Therapeutics·Ludovic BourréAlexander J MacRobert
Oct 21, 2009·Current Opinion in Infectious Diseases·Moira A McMahonRobert F Siliciano
Oct 23, 2010·Bioorganic & Medicinal Chemistry Letters·Hitesh K AgarwalKeykavous Parang
Mar 9, 2011·Bioorganic & Medicinal Chemistry Letters·Hitesh K AgarwalKeykavous Parang
Feb 16, 2011·Tetrahedron Letters·Yousef AhmadibeniKeykavous Parang
Citations
Dec 5, 2013·Chemical Reviews·Jiang WangHong Liu
Jun 4, 2014·Journal of Peptide Science : an Official Publication of the European Peptide Society·Michał DobkowskiPiotr Mucha
Mar 30, 2017·Bioorganic & Medicinal Chemistry Letters·Hitesh K AgarwalKeykavous Parang
Jul 6, 2014·Beilstein Journal of Organic Chemistry·Oliver RiesChristian Ducho
May 27, 2020·Journal of Cellular Physiology·Roghayeh SheervalilouZiba Nazarlou
Jun 2, 2012·Organic & Biomolecular Chemistry·Jia-Yan LiuShu-Jiang Tu
Aug 25, 2012·Molecular Pharmaceutics·Hitesh K AgarwalKeykavous Parang
Apr 10, 2015·Chemical Reviews·Pier Alexandre ChampagneJean-François Paquin